Greenspace Labs

Using cannabinoids in a patent pending Phase IIa trial for IBS

Facebook Twitter LinkedIn

We are a patent pending pharma company completing a Phase IIa study using cannabinoids in the treatment of IBS

Fundraise Details

This section is only visible to registered investors. Log in or register as an accredited investor to view.

Ready to Ask For Funding for your company?

Post a Funding Request